Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016).
Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence,
and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Formulation and In Vitro Evaluation of Rifampicin Loaded Porous Microspheres
Biopharmaceutical Research Group, Dpt. of Biopharmaceutics, Govt. College of Pharmacy, Karad, India
Author to whom correspondence should be addressed.
Received: 16 October 2009
Accepted: 12 April 2010
Published: 18 April 2010
Rifampicin (RIF) is a major component in fixed dose combination therapy for the treatment of tuberculosis. RIF has low solubility and high permeability with high dose and hence it is classified as class II drug in Biopharmaceutical Classification System (BCS). RIF has poor and variable bioavailability because of its poor solubility, acid decomposition and, drug and food interaction. The present investigation was aimed to develop RIF loaded porous microspheres as a controlled release dosage form. Eudragit based porous microspheres of RIF were prepared by emulsion solvent diffusion method. Prepared porous microspheres were evaluated for its entrapment efficacy, morphology, thermal behavior, crystalline nature, in-vitro drug release and stability in simulated gastric fluid. The entrapment efficacy of drug loaded microspheres was found to be in the range of 19.04–74.57%. Surface morphology revealed the porous and spherical structure of microspheres. Differential scanning calorimetric studies confirmed that formulation process altered the crystalline nature of RIF. In vitro drug release studies indicated that drug to polymer ratio of 2:1 showed more than 85% drug release over the period of 3 h. Stability studies in simulated gastric fluid (SGF) indicated that low relative decomposition of 18.5% was achieved with high drug to low polymer ratio of 1:4. The results obtained from the present investigation concluded that RIF loaded porous microspheres are suitable for developing oral controlled release dosage form of RIF that can prevent acid decomposition and provide better biopharmaceutical properties. Further more the microspheres can be evaluated for preventing the interaction with isoniazid, other drugs and foodstuffs.
Share and Cite
MDPI and ACS Style
BHISE, S.B.; MORE, A.B.; MALAYANDI, R.
Formulation and In Vitro Evaluation of Rifampicin Loaded Porous Microspheres. Sci. Pharm. 2010, 78, 291-302.
BHISE SB, MORE AB, MALAYANDI R.
Formulation and In Vitro Evaluation of Rifampicin Loaded Porous Microspheres. Scientia Pharmaceutica. 2010; 78(2):291-302.
BHISE, Satish Balakrishna, Avinash Bhanudas MORE, and Rajkumar MALAYANDI.
2010. "Formulation and In Vitro Evaluation of Rifampicin Loaded Porous Microspheres" Scientia Pharmaceutica 78, no. 2: 291-302.
Article Access Statistics
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.